Literature DB >> 20347380

Evaluation of natural killer cell defense in oral squamous cell carcinoma.

Mahiye Reyhan Türkseven1, Tülin Oygür.   

Abstract

This research aims to give a new insight to the relationship between host local immune response and the biological behaviour of the tumor by evaluating of intratumoral natural killer (NK) cells and tumor necrosis factor-alpha (TNFalpha) expressions in oral squamous cell carcinomas. New paraffin sections of the deepest parts of the 46 cases of oral squamous cell carcinomas were immunohistochemically treated by CD57, selected as NK cell indicator, and TNFalpha monoclonal antibodies. The tumors were graded according to histopathologic grading scores of invasive margins and categorized into 2 groups as "good" and "poor" prognostic groups. Fifteen cases, from which could be obtained full clinical data, were clinically staged and because of the scarcity of the cases in each group were divided, again, two groups as group 1: stage I+stage II and group 2: stage III+stage IV. The expression levels of CD57 and TNFalpha were evaluated according to histopathologic grading groups and clinical staging groups. The results showed that the density of CD57+cells (NK cells) was statistically lower in tumors graded as poor prognostic group compared to the cases in good prognostic group. On the contrary, expression level of TNFalpha was statistically higher in poor prognostic group. These findings suggested that increased secretion of TNFalpha in the tumors, which show high invasive potential, may be one of the facilitating factors for tumor invasion and be responsible from suppression of NK cells. Withdrawal of NK cells in the high invasive tumor areas also reminds the necessity of certain shared genetic rearrangements in tumor cells for getting protected from NK cell attacks and moving ahead within the extracellular matrix. Copyright (c) 2010 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20347380     DOI: 10.1016/j.oraloncology.2010.02.019

Source DB:  PubMed          Journal:  Oral Oncol        ISSN: 1368-8375            Impact factor:   5.337


  11 in total

1.  Low-risk population among patients with tumor-node-metastasis stage III/IV oral squamous cell carcinoma.

Authors:  Tohru Ikeda; Sachiko Seki; Mutsunori Fujiwara; Masaaki Matsuura; Yuu Ozaki-Honda; Shuichi Fujita; Hisazumi Ikeda; Masahiro Umeda; Izumi Asahina
Journal:  Oncol Lett       Date:  2017-07-15       Impact factor: 2.967

2.  Super-charged NK cells inhibit growth and progression of stem-like/poorly differentiated oral tumors in vivo in humanized BLT mice; effect on tumor differentiation and response to chemotherapeutic drugs.

Authors:  Kawaljit Kaur; Paytsar Topchyan; Anna Karolina Kozlowska; Nick Ohanian; Jessica Chiang; Phyu Ou Maung; So-Hyun Park; Meng-Wei Ko; Changge Fang; Ichiro Nishimura; Anahid Jewett
Journal:  Oncoimmunology       Date:  2018-02-22       Impact factor: 8.110

Review 3.  The critical role of the tumor microenvironment in shaping natural killer cell-mediated anti-tumor immunity.

Authors:  Joanna Baginska; Elodie Viry; Jérôme Paggetti; Sandrine Medves; Guy Berchem; Etienne Moussay; Bassam Janji
Journal:  Front Immunol       Date:  2013-12-25       Impact factor: 7.561

Review 4.  Pathogen-Associated Molecular Patterns Induced Crosstalk between Dendritic Cells, T Helper Cells, and Natural Killer Helper Cells Can Improve Dendritic Cell Vaccination.

Authors:  Tammy Oth; Joris Vanderlocht; Catharina H M J Van Elssen; Gerard M J Bos; Wilfred T V Germeraad
Journal:  Mediators Inflamm       Date:  2016-02-11       Impact factor: 4.711

5.  Peritoneal NK cells are responsive to IL-15 and percentages are correlated with outcome in advanced ovarian cancer patients.

Authors:  Ralph J Maas; Jolien van der Meer; Leon Massuger; Harry Dolstra; Janneke S Hoogstad-van Evert; Jeannette Cany; Sophieke van der Steen; Joop H Jansen; Jeffrey S Miller; Ruud Bekkers; Willemijn Hobo
Journal:  Oncotarget       Date:  2018-10-05

6.  The prognostic role of NK cells and their ligands in squamous cell carcinoma of the head and neck: a systematic review and meta-analysis.

Authors:  Sangeeta K Bisheshar; Emma J De Ruiter; Lot A Devriese; Stefan M Willems
Journal:  Oncoimmunology       Date:  2020-04-23       Impact factor: 8.110

Review 7.  The Role of GSK-3 in Cancer Immunotherapy: GSK-3 Inhibitors as a New Frontier in Cancer Treatment.

Authors:  Giuseppa Augello; Maria R Emma; Antonella Cusimano; Antonina Azzolina; Giuseppe Montalto; James A McCubrey; Melchiorre Cervello
Journal:  Cells       Date:  2020-06-09       Impact factor: 6.600

Review 8.  Functional Significance of CD57 Expression on Human NK Cells and Relevance to Disease.

Authors:  Carolyn M Nielsen; Matthew J White; Martin R Goodier; Eleanor M Riley
Journal:  Front Immunol       Date:  2013-12-09       Impact factor: 7.561

9.  The Potential of CD16 on Plasma-Derived Exosomes as a Liquid Biomarker in Head and Neck Cancer.

Authors:  Linda Hofmann; Sonja Ludwig; Patrick J Schuler; Thomas K Hoffmann; Cornelia Brunner; Marie-Nicole Theodoraki
Journal:  Int J Mol Sci       Date:  2020-05-26       Impact factor: 5.923

Review 10.  Biomarkers: paving stones on the road towards the personalized precision medicine for oral squamous cell carcinoma.

Authors:  Liang Zhong; Yutong Liu; Kai Wang; Zhijing He; Zhaojian Gong; Zhili Zhao; Yaocheng Yang; Xiaofei Gao; Fangjie Li; Hanjiang Wu; Sheng Zhang; Lin Chen
Journal:  BMC Cancer       Date:  2018-09-21       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.